Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive piracetam with methylphenidate in children with ADHD
IRCT20111207008317N3Phase 3Recruiting
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of piracetam, methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Sep 2026; status: recruiting.
02
Drugs
piracetammethylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT20111207008317N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20111207008317N3.